Created at 1:59 p.m. Jun, 10, 2026
Author:
madrice
Type of change:
Updated content
Rationale for change
The hypertension guidelines have been updated as of 2025. One of the biggest changes is that they are no longer stratifying anti-hypertensive choice by race. https://international.heart.org/en/news-and-events/2025/august-high-blood-pressure
Current
Suggested
Text
Text
Text
Text
Extra
- The 2020 ISH Global Hypertension Practice Guidelines list first-line pharmacologic treatment of HTN in Black patients as either HCTZ + DHP-CCB or ARB + DHP-CCB
- This is a commonly tested concept and follows current ACC/AHA guidelines, which state: "In black adults with hypertension but without HF or CKD, including those with DM, initial antihypertensive treatment should include a thiazide-type diuretic or CCB"
- These guidelines have recently come under scrutiny within the medical community due to concerns about race-based biases, as race is a social construct rather than a biologically meaningful scientific category; read more here
- This is a commonly tested concept and follows current ACC/AHA guidelines, which state: "In black adults with hypertension but without HF or CKD, including those with DM, initial antihypertensive treatment should include a thiazide-type diuretic or CCB"
- These guidelines have recently come under scrutiny within the medical community due to concerns about race-based biases, as race is a social construct rather than a biologically meaningful scientific category; read more here
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Watch Primary Hypertension & Hypertensive Emergency
Watch Calcium Channel Blockers
Watch Thiazides
Watch Thiazides
Sketchy 2
Watch Hypertension Management
Watch Hypertension Management
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Review Dihydropyridines
Review Dihydropyridines
Physeo
OME
Empty field
Additional Resources
Empty field
One by one
Empty field